Fresh Rounds

Avery Therapeutics, Inc. funding

Avery Therapeutics, Inc., a biotechnology company based in Tucson, AZ, filed a Form D with the SEC on September 21, 2026 and reported $8.5M raised of a $15.4M offering.

Amount raised$8.5M
Offering size$15.4M
Filed with the SECSeptember 21, 2026
First saleAugust 19, 2026
IndustryBiotechnology
SecuritiesEquity
LocationTucson, AZ
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far23
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in Arizona